Analyst consensus rating
Niagen Bioscience Analyst Rating: Strong Buy
Direct answer
Niagen Bioscience's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.67.
Forecast evidence checked November 18, 2026.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.04
- Average price target
- $10.67
- High price target
- $22.00
- Low price target
- $6.00
- Low target gap
- +194.1%
- Target upside
- +422.9%
- High target gap
- +978.4%
- Target range width
- 784.3%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- November 18, 2026
- Valid through
- November 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Niagen Bioscience?
Niagen Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $10.67.
How far are Niagen Bioscience's low and high targets from the recorded price?
The low target implies +194.1%, while the high target implies +978.4%.
How many analysts are included in Niagen Bioscience's consensus?
The verified consensus includes 6 analysts.
How is Niagen Bioscience's target upside or downside calculated?
The average target of $10.67 is divided by the recorded price of $2.04, then one is subtracted to produce +422.9%. This does not guarantee a future return.
When was Niagen Bioscience's analyst forecast verified?
The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.